LifeMD, Inc.

NASDAQ:LFMD

Medical - Pharmaceuticals

Healthcare
$1.70 -3.27%

-$0.16 today

Market cap
$82.17M
Beta
1.99
P/E (TTM)
-13.8
EPS (TTM)
-$0.34
52W Low $2.56High $15.84

Volume 0.80M

Average 1.04M

LFMD Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

LifeMD, Inc.NASDAQ: LFMD

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables turns positive

Q1 FY2026 accounts payables was $7.5M, compared with -$330.46K a year earlier. Trailing-twelve-month accounts payables was $11.08M. Over 3 fiscal years it compounded at +37.4% a year.

Context

  • Accounts payables amounted to 1.7% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly accounts payables holds near $7.5M or moves back toward the trailing-twelve-month quarterly average of $2.77M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$7.5M+2594.9% QoQ
Last fiscal yearDec 2025
$3.24M-34.1% YoY
LTMMar 2026
$11.08M+237.4% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2370.8%——
1 year-34.1%——
3-year CAGR+37.4%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
3.24M USD
Year-over-year change
-34.1%

Accounts Payables vs competitors

How LFMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +237.4% is the 2nd highest of 9, against a peer median of -26.4%.
  • Accounts payables amounts to 5.0% of revenue for LFMD, versus a peer median of 1.6%.
LFMD Competitors
Accounts Payables for LFMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LFMDLifeMD, Inc.LTM Mar 2026$11.08M USD+237.4%+37.4%5.0%
TBRGTruBridge, Inc.LTM Mar 2026$7.61M USD+175.5%—2.2%
CERSCerus CorporationLTM Mar 2026$4.83M USD-50.2%—2.2%
SGHTSight Sciences, Inc.LTM Mar 2026$1.28M USD-223.1%-20.6%1.6%
SENSSenseonics Holdings, Inc.LTM Mar 2026$1.2M USD-2.7%—2.9%
MASS908 Devices Inc.LTM Mar 2026$964K USD——1.7%
SMTISanara MedTech Inc.LTM Mar 2026$781.12K USD-162.9%—0.7%
HITIHigh Tide Inc.LTM Apr 2026CA$283K CAD-56.4%—0.0%
CVRXCVRx, Inc.LTM Mar 2026$248K USD+73.4%+1.1%0.4%
TKNOAlpha Teknova, Inc.LTM Mar 2026$60K USD+361.5%-6.3%0.1%
Peer median (excluding LFMD) —-26.4%-6.3%1.6%

Competitors are the stored peer set for LFMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(61.32M)(45.02M)(20.6M)(18.73M)15.62M
Depreciation & Amortization868.76K3.77M6.6M9.49M328.37K
Deferred Income Tax0354K000
Stock-Based Compensation12.07M13.73M12.49M12.23M10.5M
Change in Working Capital9.13M(1.55M)4.91M12.65M(7.85M)
Accounts Receivables17.7K(2.19M)(2.44M)(2.94M)1.15M
Inventory(409.82K)(2.18M)764.33K675.67K303.24K
Accounts Payables(893.96K)1.25M978.06K4.92M3.24M
Other Working Capital10.42M1.58M5.61M9.99M(12.55M)
Other Non-Cash Items6.17M5.78M5.42M1.87M(10.31M)
Operating Cash Flow(33.09M)(22.94M)8.82M17.51M8.28M
Capital Expenditures(3.4M)(12.89M)(8.73M)(11.54M)(9.52M)
Acquisitions (Net)0(1.01M)000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(3.15M)(12.53M)(8.53M)(10.05M)8.78M
Investing Cash Flow(3.4M)(13.91M)(8.73M)(11.54M)6.91M
Debt Repayment(530.82K)2.74M16.67M(327.6K)(18.72M)
Common Stock Issued13.99M016.2M09.19M
Common Stock Repurchased00000
Dividends Paid(871.48K)(3.11M)(3.11M)(3.11M)(3.11M)
Other Financing Activities707.36K(159.2K)(667.63K)(684.83K)(773.66K)
Financing Cash Flow68.64M(528.2K)29.1M(4.12M)(13.41M)
Effect of Forex Changes00000
Net Change in Cash32.15M(37.37M)29.19M1.86M1.78M
Free Cash Flow(36.49M)(35.83M)86.95K5.98M(1.24M)

LifeMD, Inc.

NASDAQ:LFMD

Intrinsic Alpha fair value

Locked

Current Price

$1.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.